Rebekah Sayers

Unveiling the power of ZT Scan DIA: Insights from Ludwig Sinn’s presentation at World HUPO Congress 2024

Feb 7, 2025 | Blogs, Life Science Research, Proteomics, ZenoTOF 7600 system | 0 comments

Read time: 3 minutes

In a recent presentation at the World HUPO Congress 2024, Ludwig Sinn from the Ralser lab shared exciting advancements in proteomics research, focusing on the innovative ZT Scan DIA acquisition modes developed in collaboration with SCIEX. Let us explore the key highlights and benefits of this innovative technology.

The evolution of SWATH DIA

Ludwig began by discussing the evolution from the traditional SWATH DIA approach to the more advanced Zeno trap-enabled scanning DIA (ZT Scan DIA). While SWATH DIA has been a cornerstone in proteomics, it has limitations, particularly the time-consuming filling and emptying of the collision cell for each SWATH isolation window. ZT Scan DIA addresses this by leveraging a sliding Q1 quadrupole, which enhances specificity and speed by correlating fragment ions across the scanning quadrupole dimension.

Introducing the ZenoTOF system family

When SCIEX launched the ZenoTOF 7600 system in 2021, it came with two significant innovations:

The electron-activated dissociation (EAD) collision cell allows versatile fragmentation mechanisms.
The Zeno trap: trapping ions to improve the duty cycle in TOF MS/MS scans significantly boosts low-abundance signals’ intensity.

These enhancements translated to better coverage of low-abundance ions, increased sensitivity and more robust system performance.

Then, SCIEX introduced Zeno SWATH DIA, capitalizing on the Zeno trap capabilities and significant sensitivity gains to MS/MS data acquisition. Zeno SWATH DIA could reveal tens, hundreds and even thousands more identified and quantified analytes in a shorter time and with higher precision.

Combining the scanning quadrupole dimension with Zeno trapping

The natural progression was to combine the benefits of the scanning quadrupole dimension with the Zeno trap capabilities in the new ZenoTOF 7600+ system. Ludwig shared initial data showing impressive gains in identification consistency and data completeness, particularly at lower loads and faster gradients. For example, using a mere five nanograms of K562 proteome digestion standard, the ZT Scan DIA approach showed a significant increase in IDs compared to Zeno SWATH DIA.

Performance across different gradients and loads

Ludwig’s team rigorously tested ZT Scan DIA across separation speeds and loading inputs. The results were compelling, with ZT Scan DIA consistently outperforming Zeno SWATH DIA, especially at lower loads and faster gradients. This makes ZT Scan DIA an excellent choice for high-throughput proteomics, offering speed and depth without compromising quantitative precision.

Advancing quantitative precision

One of the standout features of ZT Scan DIA is its ability to maintain high quantitative precision. Ludwig highlighted that ZT Scan DIA effectively removes ratio compression and quantitative bias, providing reliable results across a wide dynamic range. This was evident in their LFQ benchtop test analysis, where ZT Scan DIA outperformed Zeno SWATH DIA in terms of quantitative precision.

Exploring glycoproteomics with ZT Scan DIA

Ludwig also touched upon the potential of ZT Scan DIA in the emerging field of glycoproteomics. By leveraging the scanning quadrupole dimension to identify oxonium ions, the team could achieve high-resolution analysis of glycopeptide features, making ZT Scan DIA a powerful tool for studying glycoproteins.

Conclusion

Ludwig’s presentation at the World HUPO Congress 2024 highlighted the remarkable advancements brought by ZT Scan DIA. With enhanced specificity, speed and quantitative precision, ZT Scan DIA is set to revolutionize proteomics research, offering unparalleled performance for high-throughput and detailed analyses.

Watch Ludwig’s presentation here.

PFAS testing: 2024 in review and what to expect for 2025

For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.

Inside the box: Acoustic ejection mass spectrometry for drug discovery

On average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.

Exploring the power of ZT Scan DIA

In a recent presentation, Tim Heymann from Mann Lab at the Max Planck Institute of Biochemistry shared his first impressions of ZT Scan DIA, the novel data-independent acquisition strategy from SCIEX, highlighting its innovative approach and significant benefits for proteomics research. Let’s dive into the key points from his insightful talk.

Posted by

Rebekah Sayers

I developed a foundational understanding of biochemistry during my undergraduate studies before gaining a masters in molecular and cellular biophysics, and finally obtaining my Ph.D conducting in-depth proteomics research in peanut allergy. I started at SCIEX in the applications support team, later being promoted to the application lead for life science research in EMEAI. I am currently leading global strategic marketing efforts, contributing to the advancement of small molecule OMICS. This role is pivotal in bridging the gap between scientific innovation and market demand, ensuring that products and workflows not only meet the needs of the market but also stand out in a competitive landscape.

0 Comments